Biology Reference
In-Depth Information
Escherichia coli: rescue of replication-competent
virus progeny and packaging of amplicon vec-
tors. Hum Gene Ther 9:2787-2794
26. Tanaka M, Kagawa H, Yamanashi Y, Sata T,
Kawaguchi Y (2003) Construction of an
excisable bacterial artifi cial chromosome con-
taining a full-length infectious clone of herpes
simplex virus type 1: viruses reconstituted
from the clone exhibit wild-type properties in
vitro and in vivo. J Virol 77:1382-1391
27. Fraefel C, Song S, Lim F, Lang P, Yu L, Wang
Y, Wild P, Geller AI (1996) Helper virus-free
transfer of herpes simplex virus type 1 plasmid
vectors
virus-mediated gene transfer. Diabetologia
50:1550-1558
36. Paradiso B, Marconi P, Zucchini S, Berto E,
Binaschi A, Bozac A, Buzzi A, Mazzuferi M,
Magri E, Mora GN et al (2009) Localized
delivery of fi broblast growth factor-2 and
brain-derived neurotrophic factor reduces
spontaneous seizures in an epilepsy model.
Proc Natl Acad Sci USA 106:7191-7196
37. Furlan R, Bergami A, Brambilla E, Butti E,
De Simoni MG, Campagnoli M, Marconi P,
Comi G, Martino G (2007) HSV-1-mediated
IL-1 receptor antagonist gene therapy
ameliorates MOG(35-55)-induced experi-
mental autoimmune encephalomyelitis in
C57BL/6 mice. Gene Ther 14:93-98
38. Puskovic V, Wolfe D, Wechuck J, Krisky D,
Collins J, Glorioso JC, Fink DJ, Mata M
(2006) HSV-mediated delivery of erythro-
poietin restores dopaminergic function in
MPTP-treated mice. Mol Ther 14:710-715
39. Glorioso JC, Fink DJ (2009) Herpes vector-
mediated gene transfer in the treatment of
chronic pain. Mol Ther 17:13-18
40. Wolfe D, Hao S, Hu J, Srinivasan R, Goss J,
Mata M, Fink DJ, Glorioso JC (2007)
Engineering an endomorphin-2 gene for use
in neuropathic pain therapy. Pain 133:29-38
41. Wolfe D, Mata M, Fink DJ (2009) A human
trial of HSV-mediated gene transfer for the
treatment of chronic pain. Gene Ther 16:
455-460
42. Martino S, Marconi P, Tancini B, Dolcetta D,
De Angelis MG, Montanucci P, Bregola G,
Sandhoff K, Bordignon C, Emiliani C et al
(2005) A direct gene transfer strategy via
brain internal capsule reverses the biochemi-
cal defect in Tay-Sachs disease. Hum Mol
Genet 14:2113-2123
43. Berges BK, Yellayi S, Karolewski BA, Miselis
RR, Wolfe JH, Fraser NW (2006)
Widespread correction of lysosomal storage
in the mucopolysaccharidosis type VII
mouse brain with a herpes simplex virus
type 1 vector expressing beta-glucuroni-
dase. Mol Ther 13:859-869
44. Sun M, Kong L, Wang X, Lu XG, Gao Q,
Geller AI (2005) Comparison of the capability
of GDNF, BDNF, or both, to protect nigros-
triatal neurons in a rat model of Parkinson's
disease. Brain Res 1052:119-129
45. Corso TD, Torres G, Goulah C, Roy I,
Gambino AS, Nayda J, Buckley T, Stachowiak
EK, Bergey EJ, Pudavar H et al (2005)
Assessment of viral and non-viral gene trans-
fer into adult rat brains using HSV-1, calcium
phosphate and PEI-based methods. Folia
Morphol (Warsz) 64:130-144
into
neural
cells.
J
Virol
70:7190-7197
28. Saeki Y, Fraefel C, Ichikawa T, Breakefi eld
XO, Chiocca EA (2001) Improved helper
virus-free packaging system for HSV ampli-
con vectors using an ICP27-deleted, over-
sized HSV-1 DNA in a bacterial artifi cial
chromosome. Mol Ther 3:591-601
29. Zaupa C, Revol-Guyot V, Epstein AL (2003)
Improved packaging system for generation of
high levels non-cytotoxic HSV-1 amplicon
vectors using Cre-loxP site-specifi c recombi-
nation to delete the packaging signals of
defective helper genomes. Hum Gene Ther
14:1049-1063
30. Burton EA, Bai Q, Goins WF, Glorioso JC
(2002) Replication-defective genomic herpes
simplex vectors: design and production. Curr
Opin Biotechnol 13:424-428
31. Krisky DM, Wolfe D, Goins WF, Marconi
PC, Ramakrishnan R, Mata M, Rouse RJ,
Fink DJ, Glorioso JC (1998) Deletion of
multiple immediate-early genes from herpes
simplex virus reduces cytotoxicity and permits
long-term gene expression in neurons. Gene
Ther 5:1593-1603
32. Berto E, Bozac A, Marconi P (2005)
Development and application of replication-
incompetent HSV-1-based vectors. Gene
Ther 12(Suppl 1):S98-S102
33. Chattopadhyay M, Walter C, Mata M, Fink
DJ (2009) Neuroprotective effect of herpes
simplex virus-mediated gene transfer of eryth-
ropoietin in hyperglycemic dorsal root gan-
glion neurons. Brain 132:879-888
34. Chattopadhyay M, Mata M, Fink DJ (2008)
Continuous delta-opioid receptor activation
reduces neuronal voltage-gated sodium chan-
nel (NaV1.7) levels through activation of pro-
tein kinase C in painful diabetic neuropathy. J
Neurosci 28:6652-6658
35. Chattopadhyay M, Mata M, Goss J, Wolfe D,
Huang S, Glorioso JC, Fink DJ (2007)
Prolonged preservation of nerve function in
diabetic neuropathy in mice by herpes simplex
Search WWH ::
Custom Search